Learning Curve Length Estimated for Minimally Invasive Distal Pancreatectomy
MONDAY, July 3, 2023 (HealthDay News) — The learning curve length for minimally invasive distal pancreatectomy (MIDP) is estimated at 85 procedures for the primary textbook outcome (TBO), according to a study published online June 28 in JAMA Surgery….
Learn MoreCertain Cancers Are on the Rise Among Hispanic Americans
MONDAY, July 3, 2023 (HealthDay News) — Cancer death rates among Hispanic Americans have declined in general over the past two decades, but for certain cancers the outlook has only gotten worse, a new study finds.First, the good news: Thanks to impro…
Learn MorePancreatic Neuroendocrine Tumors: Slow-Growing and Often Curable
MONDAY, June 19, 2023 (HealthDay News) — Pancreatic cancer is often considered a death sentence, typically aggressive and usually caught late, but there is one type of pancreatic cancer that is far more treatable.While over 90% of pancreatic cancers…
Learn MoreASCO: Minimally Invasive Noninferior to Open Surgery for Pancreatic Cancer
THURSDAY, June 1, 2023 (HealthDay News) — For patients with resectable pancreatic cancer, minimally invasive distal pancreatectomy (MIDP) is noninferior to open distal pancreatectomy (ODP), according to a study presented at the annual meeting of the …
Learn MoreUna cirugía mínimamente invasiva podría ser una buena opción en el cáncer de páncreas
VIERNES, 26 de mayo de 2023 (HealthDay News) — La cirugía mínimamente invasiva funciona igual de bien que la cirugía abierta a gran escala para eliminar los cánceres de páncreas en etapa temprana, lo que permite a los pacientes una recuperación más r…
Learn MoreMinimally Invasive Surgery May Be Good Option for People With Pancreatic Cancer
FRIDAY, May 26, 2023 (HealthDay News) — Minimally invasive surgery works just as well as full-scale open surgery in removing early-stage pancreatic cancers, allowing patients a faster recovery with less infection risk, a new clinical trial has found….
Learn MoreUna vacuna ralentiza la recurrencia del cáncer de páncreas en un ensayo inicial
JUEVES, 11 de mayo de 2023 (HealthDay News) — Una vacuna personalizada, dirigida a los genes, podría retrasar la recurrencia del cáncer de páncreas, según un ensayo de tamaño reducido, pero promisorio. La vacuna de ARNm, que se adaptó a la genética d…
Learn MoreArtificial Intelligence Improves Prediction of Pancreatic Cancer
FRIDAY, May 12, 2023 (HealthDay News) — Artificial intelligence (AI) can improve the design of surveillance programs for pancreatic cancer, according to a study published online May 8 in Nature Medicine.Davide Placido, from the University of Copenhag…
Learn MoreOverweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
THURSDAY, May 11, 2023 (HealthDay News) — Overweight and obese body mass indices (BMIs) in early and middle adulthood are associated with a higher risk for colorectal cancer (CRC) and non-CRC gastrointestinal (GI) cancers, according to a study publis…
Learn MoreVaccine Slows Return of Pancreatic Cancer in Early Trial
THURSDAY, May 11, 2023 (HealthDay News) – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial.The mRNA vaccine, which was tailored to the genetic makeup of each patient’s tumor, wor…
Learn More